Latest News
Goldman Sachs warns of possible restructuring of UK operations
Investment bank Goldman Sachs has expressed concerns that it may have to restructure its business in Britain after the country's decision to leave the European Union in June.
US trade deficit surpasses forecasts in June
America´s trade deficit with other economies jumped sharply in June as strong consumer spending stoked demand for imports.
Rex Bionics in line for £1m investment from Maxhealth
Wheelchair robot technology company Rex Bionics announced on Friday that Maxhealth Medicine has deposited £1m in escrow in relation to its subscription for 3,333,333 ordinary shares at 30p each.
Petro Matad reaches $10m settlement with Shell's Mongolian affiliate
Petroleum explorer Petro Matad’s reached a $10m settlement with Shell’s affiliate BG Mongolian Holdings (BGMH).
US open: Stocks gain after non-farm payrolls smash estimates
US stocks gained on Friday as the July non-farm payrolls report came in much better than expected.
Blue Prism indicates it will beat full-year expectations
Robotic process automation company Blue Prism updated the market on its current trading on Friday, saying it has continued to enjoy “strong” pipeline progress.
Tuesday share tips: IMI, Serco
IMI stands to prosper when recovery returns – following efforts by the company over the past few years – but that prospect now looks more distant, the Financial Times´s Lex column said.
Royal Mail Spanish unit facing competition probe
Royal Mail said the Spanish competition authority, Comisión Nacional de los Mercados y la Competencia (CNMC), had on Friday today opened formal proceedings against its GLS Spain unit, and other companies, for an alleged breach of the Spanish Competition Act.
FTSE 250 movers: Investors take note of solid Ibstock; eSure blown off course
Clay brick and concrete products manufacturer Ibstock was in favour on Friday as it announced its unaudited results for the six months to 30 June on Friday, with group revenue reaching £210. 0m compared with £148. 9m a year ago, although the comparative period only includes four months’ trading results.
Cloudcall boosts revenue and narrows loss
Cloudcall announced its unaudited interim results for the six-month period ended to 30 June on Friday, with revenue up 62% to £2. 3m.
RBS sinks into the red at the half-year stage
RBS was pushed deep into the red as a result of provisions to cover possible litigation costs linked to its 2008 rights issue just prior to its emergency rescue by taxpayers.
Directors dealings: Aviva chairman steps in and buys
Aviva chairman Sir Adrian Montague picked up shares in the life insurer which had been beaten down in 2016 on the back of worries about the impact that low interest rates will have on its profitability and the possible fall-out from Brexit.
WideCells progressing with Manchester stem cell facility
Stem cell storage and insurance company WideCells Group announced on Friday that its core division has made “rapid progress” in establishing its state of the art, stem cell laboratory based at the University of Manchester Innovation Centre.
HSBC passes on BoE base rate cut to customers
After the Bank of England lowered the base rate to 0. 25% from 0. 50%, HSBC said on Friday it will pass on the rate cut to its tracker and variable mortgage rate customers.
FTSE 100 movers: RBS gets a kicking; investors chase Rio Tinto
Royal Band of Scotland shares were in the dog house on Friday after the state-owned bank reported a stonking £2bn interim loss.
Group revenue and earnings fall at PHSC
Health, safety, hygiene and environmental consultancy company PHSC posted its preliminary results for the year to 31 March on Friday, with underlying EBITDA falling to £0. 368m from £0. 818m.
Sanne confident of growth after Brexit due to business wins
Finance administration outsourcer Sanne said despite Bexit uncertainty, new business wins and a new acquisition gives it confidence for future growth.
Audioboom in talks with Chinese fund on $8m investment
Audioboom Group, the spoken word audio on-demand platform, said it was in talks with an unnamed Chinese fund on a potential $8m investment to accelerate growth adding that it was considering a strategic acquisition.
Quantum Pharma completes Mucodis range with vaginal cream
Niche pharmaceutical developer Quantum Pharma announced on Friday that its subsidiary Colonis has launched Mucodis vaginal cream.
Week ahead: Chinese data in focus
China will take over as the main driver of markets - barring any surprises - over the coming week, with investors waiting on the release of a raft of economic indicators which might help them to gauge the health of Asia´s largest economy.